If the lynx1 and Aβ1–42 interactions are significant in vivo, lynx1 may exert protective effects against the pathological progression of AD (Thomsen et al., 2016), highlighting the need for further studies on the entire receptor complex (Thomsen and Mikkelsen, 2012). The gene discussed is LYNX1; the disease is Alzheimer disease.